Structural accelerated failure time models for survival analysis in studies with time-varying treatments

Pharmacoepidemiology and Drug Safety

Volumn 14, Issue 7, 2005, Pages 477-491

  Hernán, Miguel A ^a   Cole, Stephen R ^b   Margolick, Joseph ^b   Cohen, Mardge ^c   Robins, James M ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Jr Hospital of Cook County   (United States)

Author keywords

Causal inference; Cohort studies; Confounding

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; MORTALITY; PRIORITY JOURNAL; PROBABILITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAUSALITY; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HIV INFECTIONS; HUMANS; MALE; MULTICENTER STUDIES; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 22244474282     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.1064     Document Type: Article

References (27)

1. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: Wiley, 1980.
2. Cox DR, Oakes D. Analysis of Survival Data. London: Chapman and Hall, 1984.
3. Robins JM, Tsiatis AA. Semiparametric estimation of an accelerated failure time model with time-dependent covariates. Biometrika 1992; 79: 311-319.
4. Robins JM. Estimation of the time-dependent accelerated failure time model in the presence of confounding factors. Biometrika 1992; 79: 321-334.
5. Robins JM. A new approach to causal inference in mortality studies with a sustained exposure period application to the healthy worker survivor effect [errata appear in Math Modelling 1987; 14: 917-921]. Math Model 1986; 7: 1393-1512.
6. Hernán MA, Hernández-Díaz S, Robins JM. A structural approach to selection bias. Epidemiology 2004; 15: 615-625.
7. Cole SR, Hernán MA, Robins JM, Anastos K, Chmiel J, Detels R, Ervin C, Feldman J, Greenblatt R, Kingsley L, Lai S, Young M, Cohen M, Muñoz A. Marginal structural models to evaluate the effect of highly active antiretroviral therapies on time to AIDS or death. Am J Epidemiol 2003; 158: 687-694.
8. Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the joint effect of non-randomized treatments. J Am Stat Assoc 2001; 96: 440-448.
9. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR. The Multicenter AIDS Cohort Study: rationale, organization and selected characteristics of the participants. Am J Epidemiol 1987; 126: 310-318.
10. Barkan SE, Melnick SL, Preston-Martin S, et al. The Womens Interagency HIV Study: WIHS Collaborative Study Group. Epidemiology 1998; 9: 117-125.
11. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morbidity and Mortality Weekly Report 1992; 41: 1-19.
12. Dawid AP. Conditional independence in statistical theory (with discussion). J R Stat Soc B 1979; 41: 1-31.
13. Cole SR, Hernán MA. Fallibility in estimating direct effects. Int J Epidemiol 2002; 31: 163-165.
14. Robins JM. Structural nested failure time models. In: Survival Analysis, Andersen PK, Keiding N, Section Editors. The Encyclopedia of Biostatistics, Armitage P, Colton T (eds). Chichester, UK: John Wiley & Sons, 1997; 4372-4389.
15. Robins JM. The analysis of randomized and non-randomized AIDS treatment trials using a new approach to causal inference in longitudinal studies. In Health Services Research Methodology: A Focus on AIDS, Sechrest L, Freeman H, Mulley A (eds). Washington, DC: U.S. Public Health Service, National Center for Health Services Research, 1989; 113-159.
16. Robins JM. Analytic methods for estimating HIV treatment and cofactor effects. In Methodological Issues of AIDS Mental Health Research, Ostrow DG, Kessler R (eds). New York: Plenum Publishing, 1993.
17. Mark SD, Robins JM. A method for the analysis of randomized trials with compliance information: an application to the multiple risk factor intervention trial. Control Clin Trials 1993; 14: 79-97.
18. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cells counts of 200 per cubic millimeter or less: AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997; 337: 725-733.
19. Robins JM, Blevins D, Ritter G, Wulfsohn M. G-estimation of the effect of prophylaxis therapy for pneumocystis carinii pneumonia on the survival of AIDS patients [errata appear in Epidemiology 1993; 4: 189]. Epidemiology 1992; 3: 319-336.
20. Mark SD, Robins JM. Estimating the causal effect of smoking cessation in the presence of confounding factors using a rank preserving structural failure time model. Stat Med 1993; 12: 1605-1628.
21. Robins JM, Greenland S. Adjusting for differential rates of PCP prophylaxis in high- versus low-dose AZT treatment arms in an AIDS randomized trial. J Am Star Assoc 1994; 89: 737-749.
22. Witteman JC, dAgostino RB, Stijnen T, et al. G-estimation of causal effects: isolated systolic hypertension and cardiovascular death in the Framingham Study. Am J Epidemiol 1998; 148: 390-401.
23. Keiding N, Filiberti M, Esbjerg S, Robins JM, Jacobsen N. The graft versus leukemia effect after bone marrow transplantation: a case study using structural nested failure time models. Biometrics 1999; 55: 23-28.
24. Tilling K, Sterne JA, Szklo M. Estimating the effect of cardiovascular risk factors on all-cause mortality and incidence of coronary heart disease using G-estimation: the atherosclerosis risk in communities study. Am J Epidemiol 2002; 155: 710-718.
25. Robins JM. Commentary on 'Using inverse weighting and predictive inference to estimate the effects of time-varying treatments on the discrete-time hazard' by Dawson and Lavori. Stat Med 2002; 21: 1663-1680.
26. Thompson WA, Jr. On the treatment of grouped observations in life studies. Biometrics 1977; 33: 463-470.
27. Robins JM, Finkelstein D. Correcting for non-compliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics 2000; 56: 779-788.